Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(13%)
Terminated
1(13%)

Phase Distribution

Ph phase_1
1
13%
Ph not_applicable
2
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Not yet recruiting2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

not_yet_recruiting225%
terminated113%
recruiting113%
unknown450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8